Similar Items: Targeting Hepatic Glycerolipid Synthesis and Turnover to Treat Fatty Liver Disease
- Concepts and Treatment Approaches in Nonalcoholic Fatty Liver Disease
- NADPH Oxidases in Chronic Liver Diseases
- Impairments in signaling cascades mediating the progression of liver disease from chronic hepatitis to hepatocellular carcinoma in animal and human models
- Prognosis prediction by urinary liver-type fatty acid-binding protein in patients in the intensive care unit admitted from the emergency department: A single-center, historical cohort study
- Hepatic Monoclonal Light‐ and Heavy‐Chain Deposition Disease Presenting as Noncirrhotic Portal Hypertension With Ascites
- Primary Liver Cancer Trends Worldwide and in China: Analysis of GLOBOCAN 2022 Data and Disease Management Implications